Thermoradiotherapy combined with adenoviral p53 gene therapy in head and neck squamous cell carcinoma cell lines

Yuzuru Higuchi, Jun-Ichi Asaumi, Jun Murakami, Hidenobu Matsuzaki, Toru Wakasa, Tetsuyoshi Inoue, Hironobu Konoucni, Miki Hisatomi, Yoshinobu Yanagi, Yasutoshi Honda, Hiroshi Shigehara, Kanji Kishi

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

We examined effects of recombinant p53-expressing adenovirus combined with thermoradiotherapy in 8 head and neck squamous cell carcinoma (SCC) cell lines to improve the outcomes of the threatment of advanced head and neck cancer. The p53 gene therapy did not improve the discrepancy between thermoradiosensitivities among the 8 SCC cell lines. However, p53 gene therapy improved the effects of thermoradiotherapy in all 8 cell lines, and there were significant differences in four situations of the HSC4 44°C (p=0.032), SAS at 44°C (p=0.029), the KB at 43°C (p=0.025), and the Ca9-22 43°C (p=0.020). In comparing the survival rates of thermoradiotherapy with those of thermotherapy and radiotherapy, thermoradiotherapy demonstrated actual survival rates less than theoretical survival rates based on the survival rates of thermotherapy multiplied by the survival rates of radiotherapy in almost all treatments of thermoradio-gene therapy of the 8 SCC cell lines. These results demonstrate that thermoradiotherapy combined with p53 gene therapy may be a useful tool in treating SCC cells.

Original languageEnglish
Pages (from-to)415-420
Number of pages6
JournalOncology Reports
Volume10
Issue number2
Publication statusPublished - Mar 2003

Fingerprint

p53 Genes
Genetic Therapy
Cell Line
Squamous Cell Carcinoma
Induced Hyperthermia
Radiotherapy
Head and Neck Neoplasms
Adenoviridae
Carcinoma, squamous cell of head and neck
Therapeutics

Keywords

  • Conservative combined therapy
  • Gene therapy
  • p53
  • Radiotherapy
  • Thermotherapy

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Thermoradiotherapy combined with adenoviral p53 gene therapy in head and neck squamous cell carcinoma cell lines. / Higuchi, Yuzuru; Asaumi, Jun-Ichi; Murakami, Jun; Matsuzaki, Hidenobu; Wakasa, Toru; Inoue, Tetsuyoshi; Konoucni, Hironobu; Hisatomi, Miki; Yanagi, Yoshinobu; Honda, Yasutoshi; Shigehara, Hiroshi; Kishi, Kanji.

In: Oncology Reports, Vol. 10, No. 2, 03.2003, p. 415-420.

Research output: Contribution to journalArticle

Higuchi, Y, Asaumi, J-I, Murakami, J, Matsuzaki, H, Wakasa, T, Inoue, T, Konoucni, H, Hisatomi, M, Yanagi, Y, Honda, Y, Shigehara, H & Kishi, K 2003, 'Thermoradiotherapy combined with adenoviral p53 gene therapy in head and neck squamous cell carcinoma cell lines', Oncology Reports, vol. 10, no. 2, pp. 415-420.
Higuchi, Yuzuru ; Asaumi, Jun-Ichi ; Murakami, Jun ; Matsuzaki, Hidenobu ; Wakasa, Toru ; Inoue, Tetsuyoshi ; Konoucni, Hironobu ; Hisatomi, Miki ; Yanagi, Yoshinobu ; Honda, Yasutoshi ; Shigehara, Hiroshi ; Kishi, Kanji. / Thermoradiotherapy combined with adenoviral p53 gene therapy in head and neck squamous cell carcinoma cell lines. In: Oncology Reports. 2003 ; Vol. 10, No. 2. pp. 415-420.
@article{1bbf9ef6aced4af09caf61d75ca07696,
title = "Thermoradiotherapy combined with adenoviral p53 gene therapy in head and neck squamous cell carcinoma cell lines",
abstract = "We examined effects of recombinant p53-expressing adenovirus combined with thermoradiotherapy in 8 head and neck squamous cell carcinoma (SCC) cell lines to improve the outcomes of the threatment of advanced head and neck cancer. The p53 gene therapy did not improve the discrepancy between thermoradiosensitivities among the 8 SCC cell lines. However, p53 gene therapy improved the effects of thermoradiotherapy in all 8 cell lines, and there were significant differences in four situations of the HSC4 44°C (p=0.032), SAS at 44°C (p=0.029), the KB at 43°C (p=0.025), and the Ca9-22 43°C (p=0.020). In comparing the survival rates of thermoradiotherapy with those of thermotherapy and radiotherapy, thermoradiotherapy demonstrated actual survival rates less than theoretical survival rates based on the survival rates of thermotherapy multiplied by the survival rates of radiotherapy in almost all treatments of thermoradio-gene therapy of the 8 SCC cell lines. These results demonstrate that thermoradiotherapy combined with p53 gene therapy may be a useful tool in treating SCC cells.",
keywords = "Conservative combined therapy, Gene therapy, p53, Radiotherapy, Thermotherapy",
author = "Yuzuru Higuchi and Jun-Ichi Asaumi and Jun Murakami and Hidenobu Matsuzaki and Toru Wakasa and Tetsuyoshi Inoue and Hironobu Konoucni and Miki Hisatomi and Yoshinobu Yanagi and Yasutoshi Honda and Hiroshi Shigehara and Kanji Kishi",
year = "2003",
month = "3",
language = "English",
volume = "10",
pages = "415--420",
journal = "Oncology Reports",
issn = "1021-335X",
publisher = "Spandidos Publications",
number = "2",

}

TY - JOUR

T1 - Thermoradiotherapy combined with adenoviral p53 gene therapy in head and neck squamous cell carcinoma cell lines

AU - Higuchi, Yuzuru

AU - Asaumi, Jun-Ichi

AU - Murakami, Jun

AU - Matsuzaki, Hidenobu

AU - Wakasa, Toru

AU - Inoue, Tetsuyoshi

AU - Konoucni, Hironobu

AU - Hisatomi, Miki

AU - Yanagi, Yoshinobu

AU - Honda, Yasutoshi

AU - Shigehara, Hiroshi

AU - Kishi, Kanji

PY - 2003/3

Y1 - 2003/3

N2 - We examined effects of recombinant p53-expressing adenovirus combined with thermoradiotherapy in 8 head and neck squamous cell carcinoma (SCC) cell lines to improve the outcomes of the threatment of advanced head and neck cancer. The p53 gene therapy did not improve the discrepancy between thermoradiosensitivities among the 8 SCC cell lines. However, p53 gene therapy improved the effects of thermoradiotherapy in all 8 cell lines, and there were significant differences in four situations of the HSC4 44°C (p=0.032), SAS at 44°C (p=0.029), the KB at 43°C (p=0.025), and the Ca9-22 43°C (p=0.020). In comparing the survival rates of thermoradiotherapy with those of thermotherapy and radiotherapy, thermoradiotherapy demonstrated actual survival rates less than theoretical survival rates based on the survival rates of thermotherapy multiplied by the survival rates of radiotherapy in almost all treatments of thermoradio-gene therapy of the 8 SCC cell lines. These results demonstrate that thermoradiotherapy combined with p53 gene therapy may be a useful tool in treating SCC cells.

AB - We examined effects of recombinant p53-expressing adenovirus combined with thermoradiotherapy in 8 head and neck squamous cell carcinoma (SCC) cell lines to improve the outcomes of the threatment of advanced head and neck cancer. The p53 gene therapy did not improve the discrepancy between thermoradiosensitivities among the 8 SCC cell lines. However, p53 gene therapy improved the effects of thermoradiotherapy in all 8 cell lines, and there were significant differences in four situations of the HSC4 44°C (p=0.032), SAS at 44°C (p=0.029), the KB at 43°C (p=0.025), and the Ca9-22 43°C (p=0.020). In comparing the survival rates of thermoradiotherapy with those of thermotherapy and radiotherapy, thermoradiotherapy demonstrated actual survival rates less than theoretical survival rates based on the survival rates of thermotherapy multiplied by the survival rates of radiotherapy in almost all treatments of thermoradio-gene therapy of the 8 SCC cell lines. These results demonstrate that thermoradiotherapy combined with p53 gene therapy may be a useful tool in treating SCC cells.

KW - Conservative combined therapy

KW - Gene therapy

KW - p53

KW - Radiotherapy

KW - Thermotherapy

UR - http://www.scopus.com/inward/record.url?scp=18544393515&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=18544393515&partnerID=8YFLogxK

M3 - Article

C2 - 12579282

AN - SCOPUS:18544393515

VL - 10

SP - 415

EP - 420

JO - Oncology Reports

JF - Oncology Reports

SN - 1021-335X

IS - 2

ER -